U.S. Markets open in 2 hrs 54 mins

Johnson & Johnson (JNJ)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
131.39-0.36 (-0.27%)
At close: 4:01PM EDT

131.35 -0.04 (-0.03%)
Pre-Market: 4:00AM EDT

People also watch
PGMRKKOPFEXOM
Full screen
Previous Close131.75
Open131.99
Bid130.20 x 300
Ask132.75 x 300
Day's Range131.27 - 132.39
52 Week Range109.32 - 137.08
Volume160
Avg. Volume5,302,198
Market Cap352.65B
Beta0.63
PE Ratio (TTM)22.23
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield3.36 (2.48%)
Ex-Dividend Date2017-08-25
1y Target EstN/A
Trade prices are not sourced from all markets
  • Could This Be Warren Buffett's Greatest Weakness?
    Motley Fool21 hours ago

    Could This Be Warren Buffett's Greatest Weakness?

    The oracle of Omaha's Achilles' heel just might be an entire industry.

  • Reuters3 days ago

    FDA declines to approve J&J arthritis drug sirukumab

    The U.S. Food and Drug Administration has declined to approve Johnson & Johnson's rheumatoid arthritis drug sirukumab, saying additional clinical data is needed to further evaluate its safety, the company said on Friday. The FDA's decision is in keeping with an advisory panel's recommendation in August that the FDA reject the drug. "We are disappointed by this development as we feel the data accumulated to date support the efficacy and safety of sirukumab," said Dr. Newman Yeilding, head of immunology at J&J's Janssen subsidiary.

  • Reuters3 days ago

    U.S. FDA rejects J&J's arthritis drug

    The U.S. Food and Drug Administration has declined to approve Johnson & Johnson's rheumatoid arthritis drug sirukumab, saying additional clinical data is needed to further evaluate its safety, the company ...